Cargando…

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer

Detalles Bibliográficos
Autores principales:	Bilyard, Hilary, Mines, Charlotte, Brunet, Laura Rosa, Dalgleish, Angus, Macintosh, Frances
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288755/ http://dx.doi.org/10.1186/2051-1426-2-S3-P83

Ejemplares similares

Treatment with IMM-101 induces protective CD8+ T cell responses in clinically relevant models of pancreatic cancer
por: Elia, Androulla, et al.
Publicado: (2013)

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016)

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016)

Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity
por: Dalgleish, Angus G., et al.
Publicado: (2018)

ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing
por: Donnellan, Zoe, et al.
Publicado: (2015)

Identification of circulatory biomarkers from clinical trial samples
por: Brunet, Laura Rosa, et al.
Publicado: (2015)

Extended Survival after Complete Pathological Response in Metastatic Pancreatic Ductal Adenocarcinoma Following Induction Chemotherapy, Chemoradiotherapy, and a Novel Immunotherapy Agent, IMM-101
por: Costa Neves, Mafalda, et al.
Publicado: (2015)

Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
por: Wang, Liang-Chuan S, et al.
Publicado: (2015)

P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
por: Lykopoulos, K, et al.
Publicado: (2014)

ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
por: Orentas, Rimas J, et al.
Publicado: (2013)

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer
por: van ‘t Land, Freek R., et al.
Publicado: (2022)

A heat-killed preparation of mycobacterium obuense can reduce metastatic burden in vivo
por: Fowler, Daniel, et al.
Publicado: (2014)

Transpositional immunity: immunotherapeutical approach against bovine leukemia virus
por: Roa-Castellanos, RA
Publicado: (2009)

Identification of potential immunotherapeutic targets in antigen presentation and costimulation networks
por: Spaapen, Robbert, et al.
Publicado: (2014)

ImmTACs: Novel bi-specific agents for targeted cancer therapy
por: Oates, Joanne, et al.
Publicado: (2013)

Immunotherapeutic potential of varicella vaccine in smoldering and cutaneous adult T-cell leukemia/lymphoma
por: Amano, M, et al.
Publicado: (2014)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

Tratado de entomología Imms
por: Richards, O. W.
Publicado: (1983)

Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
por: Freitas, Elisangela Oliveira, et al.
Publicado: (2015)

Immunomodulatory activity of SGI-110: a basis for novel chemo-immunotherapeutic combinations in cancer treatment
por: Covre, Alessia, et al.
Publicado: (2013)

Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model
por: Shafren, Darren, et al.
Publicado: (2014)

The generation and analysis of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
por: Tsang, Kwong Y, et al.
Publicado: (2015)

Adjunctive treatment of chronic idiopathic urticaria and angioedema with sulfasalazine
por: Pitt, T, et al.
Publicado: (2010)

P101: Product dose considerations for real-world hand sanitiser efficacy
por: Hines, J, et al.
Publicado: (2013)

P101: GUT MICROBIOTA IMPACT ON ANGOLAN CHILDREN WITH SICKLE CELL DISEASE
por: Brito, M, et al.
Publicado: (2022)

Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm
por: Woelke, Anna Lena, et al.
Publicado: (2011)

P02.101. Vitamin D status of female healthcare employees of childbearing age
por: Plotnikoff, G, et al.
Publicado: (2012)

AB101. Therapeutic effect of low intensity pulsed ultrasound in stress urinary incontinence
por: Yang, Bicheng, et al.
Publicado: (2016)

Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma
por: Liu, Bai, et al.
Publicado: (2014)

P-101: REMEDIAL EFFECT OF GUDUCHI SATWA IN SICKLE RED BLOOD CELLS – AN AYURVEDIC APPROACH
por: A., RAJESH, et al.
Publicado: (2022)

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy
por: Sheikh, Javaid A, et al.
Publicado: (2011)

Identification of trace mineral and nutrient deficiencies as an adjunct to treatment of eating disorders
por: Johnson, Jeremy, et al.
Publicado: (2013)

Re-measurement of $^{32}$Ar to test the IMME
por: Kreim, S
Publicado: (2012)

Novel adenoviral serotype 5 based immunotherapeutic induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
por: Morse, Michael, et al.
Publicado: (2013)

A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes
por: Slingluff, Craig L, et al.
Publicado: (2014)

A101 VIRTUAL MINDFULNESS-BASED STRESS REDUCTION FOR ADULTS WITH INFLAMMATORY BOWEL DISEASE: FEASIBILITY TRIAL PRELIMINARY RESULTS
por: Chappell, K, et al.
Publicado: (2023)

P101 Economic evaluation of diagnostic sleep studies for obstructive sleep apnoea in the adult population: a systematic review
por: Natsky, A, et al.
Publicado: (2021)

P101 Paediatric obstructive sleep apnoea in primary care: an integrative review of practitioner knowledge, practice, attitudes, and behaviours
por: Russo, K, et al.
Publicado: (2022)

Immunotherapeutic Agents for Intratumoral Immunotherapy
por: Shyr, Chih-Rong, et al.
Publicado: (2023)

VaccImm: simulating peptide vaccination in cancer therapy
por: von Eichborn, Joachim, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1s5el4gf5lvr3tlbc4l0bg11jn